I. Paul Bae

I. Paul Bae

Nessuna posizione attualmente

59 anni

Health Technology

Consumer Services

Profilo

I.
Paul Bae worked as Litigation Director at Alpha Therapeutic Corp., Vice President-Human Resources at Aerie Pharmaceuticals, Inc., and VP-Global Human Resources at St. Jude Medical LLC.
He completed his undergraduate degree at the University of California, Los Angeles and his graduate degree at Mcgeorge School of Law.

Precedenti posizioni note di I. Paul Bae

Società	Posizione	Fine
Alpha Therapeutic Corp. Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.	Consigliere Generale	-
AERIE PHARMACEUTICALS, INC.	Ufficiale delle Risorse Umane	-
ST JUDE MEDICAL INC	Direttore Amministrativo	-

Vedi nel dettaglio l'esperienza di I. Paul Bae

Formazione di I. Paul Bae

University of California, Los Angeles	Undergraduate Degree
Mcgeorge School of Law	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di I. Paul Bae

Società collegate

Aziende private	3
St. Jude Medical LLC St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.	Health Technology
Alpha Therapeutic Corp. Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.	Health Technology
Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.	Health Technology

-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.

APPROFITTANE ORA